Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$3.15 - $6.01 $388,760 - $741,730
-123,416 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.69 - $7.4 $113,301 - $178,769
-24,158 Reduced 16.37%
123,416 $579,000
Q3 2021

Nov 15, 2021

BUY
$5.12 - $6.89 $256,138 - $344,686
50,027 Added 51.29%
147,574 $912,000
Q2 2021

Aug 16, 2021

BUY
$6.21 - $7.45 $605,766 - $726,725
97,547 New
97,547 $643,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About AVEO PHARMACEUTICALS, INC.


  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.